News Focus
News Focus
Followers 27
Posts 9391
Boards Moderated 0
Alias Born 09/14/2016

Re: iron-eagle post# 127693

Wednesday, 06/08/2022 8:58:58 AM

Wednesday, June 08, 2022 8:58:58 AM

Post# of 153984
Bawhahaha, of course there is always the last sec . filing from the dead company the worthless shares are attached too.
On October 22, 2018, the Company completed the sale of certain of its assets to LCY Biotechnology Inc. (previously 9384-3076 Québec Inc.). These assets comprised all of the Company’s assets, save and except for the cash, accounts receivable and inventory of the Company, and also excluded certain U.S. based office equipment. The purchaser did not seek the assignment of the Company’s contracts, which meant that certain intellectual property under license from third parties was also not transferred to the purchaser.

This transaction was approved by the Quebec Superior Court of Justice on September 18, 2018, and by the United States Bankruptcy Court for the District of Delaware on October 9, 2018. The liquidation of the Company’s assets will result in little to no residual value for non-secured creditors, and no residual value for equity investors of the Company.

Love that last paragraph.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today